Anticoagulation versus placebo for heart failure in sinus rhythm

Author:

Shantsila Eduard1,Kozieł Monika23,Lip Gregory YH4

Affiliation:

1. University of Birmingham, Institute of Cardiovascular Sciences; City Hospital, Sandwell and West Birmingham Hospitals NHS Trust; Birmingham UK

2. Liverpool Centre for Cardiovascular Science; University of Liverpool and Liverpool Heart & Chest Hospital; Liverpool UK

3. 1st Department of Cardiology and Angiology; Silesian Centre for Heart Diseases; Zabrze Poland

4. Institute of Ageing and Chronic Disease; University of Liverpool; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference52 articles.

1. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial;Mehra;European Heart Journal

2. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease;Zannad;New England Journal of Medicine,2018

3. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study;Cokkinos;European Journal of Heart Failure,2006

4. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure;Cleland;American Heart Journal,2004

5. The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure;Anderson;American Heart Journal,1950

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3